Antwana Wright, MD
Vascular Surgery · Charleston, SCNPI 1013113885
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,290 of the $6,187 with a category attached, or 85.5%. It is spread thinly across 19 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,380 and has fallen 72.5% since, to $655 in 2025. That places this record below the midpoint for vascular surgery clinicians in SC, where the typical reported total is $7,261.
Across 62 payments — averaging $99.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Medical LLC$1K
- Shockwave Medical, Inc$1K
- W. L. Gore & Associates, Inc.$1K
- Silk Road Medical, Inc.$497
- Endologix LLC$323
- Medtronic$312
- plus $2K from 13 others
Across 22 payments — averaging $2325.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Silk Road Medical, Inc.$30K
- Boston Scientific$22K
What the payments were for
- Travel & lodging$89815%
- Food & beverage$5,29085%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Medical LLC | 12 | $1,234 |
| Shockwave Medical, Inc | 8 | $1,214 |
| W. L. Gore & Associates, Inc. | 12 | $1,068 |
| Silk Road Medical, Inc. | 5 | $497 |
| Endologix LLC | 3 | $323 |
| Medtronic(2 entities) | 4 | $312 |
| Acera Surgical, Inc. | 2 | $255 |
| Smith+Nephew | 2 | $239 |
| Kerecis Limited | 2 | $238 |
| Edwards Lifesciences | 1 | $186 |
| Cagent Vascular Inc | 1 | $157 |
| Philips North America LLC | 1 | $121 |
| Penumbra, Inc. | 1 | $95 |
| Tactile Systems Technology Inc | 1 | $62 |
| Johnson & Johnson(2 entities) | 2 | $62 |
| Baxter Healthcare | 2 | $48 |
| Lemaitre Vascular, Inc. | 1 | $31 |
| Getinge USA Sales, LLC | 1 | $24 |
| Janssen Scientific Affairs, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$1,119
- GORE VIABAHN VBX Balloon Expandable Endo$957
- Kerecis Omega3 SurgiClose$636
- ENROUTE Transcarotid Neuroprotection System$565
- Zenith Alpha$555
- ENROUTE Transcarotid Stent$419
- Zenith Spiral-Z$285
- Restrata Wound Matrix$255
- Kerecis Omega3 GraftGuide$212
- Kerecis Omega3 Marigen$212
- ENDURANT IIS$178
- Serrantor$157
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$146
- PICO 7$136
- RENASYS TOUCH$136
- Zenith$125
- (5028) IGT Devices Systems Undivided$121
- Lunderquist$115
- HawkOne$115
- RENASYS GO v2 HOME$102
How this compares
$6,187 in reported general payments places this provider in the 40th percentile of 99 vascular surgery providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 13 | $5,633 |
| Cilostazol | 35 | $687 |
| ClopidogrelClopidogrel Bisulfate | 36 | $526 |
| Gabapentin | 15 | $172 |
| Atorvastatin Calcium | 18 | $124 |
| Oxycodone Hcl | 13 | $48 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $239 | $5,63313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 99 vascular surgery providers in South Carolina.
Other vascular surgery in Charleston
- Ravi VeeraswamyCharleston$164K
- Kristian HochbergCharleston$106K
- Zachary ArthursCharleston$84K
- Jean Marie RuddyCharleston$54K
- Adam KeeferCharleston$32K
- Richard ShiCharleston$20K
- Matthew AndersonCharleston$18K
- Tru DangCharleston$17K
- Adam TaniousCharleston$16K
- Sean HislopCharleston$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.